Relationship Between Circulating Tumor Stem Cells and the Clinical Pathology

Eastern Hepatobiliary Surgery Hospital1,000 enrolled

Overview

The aim of this study is to establish a platform of detecting and sorting circulating tumor stem cells from peripheral blood in HCC patients; to investigate the relationship between circulating tumor stem cells and their effects on postoperative recurrence and metastasis, in order to provide a new therapeutic target for hepatocellular carcinoma treatment.

Study Type

OBSERVATIONAL

Enrollment

1,000

Conditions

Cancer Stem Cells Postoperative Recurrence and Metastasis Hepatocellular Carcinoma

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1. Male or female patients \> 18 years and \<=70 years of age; 2. No dysfunction in major organs; Blood routine, kidney function, cardiac function and lung function are basically normal. 3. Patients who can understand this trial and have signed information consent Exclusion Criteria: 1. Reject to attend； 2. Impossible to come to our hospital for physical examination regularly; 3. Patients with other diseases which may affect the treatment mentioned

Locations (1)

Eastern hepatobilliary surgery hospital

Shanghai, Shanghai Municipality, China

Outcomes

Primary Outcomes

the overall survival rate of each group

Time frame: 3 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.